Impact of Coronavirus on the Protein A Resin Market Growth, Trends and Competitive Landscape

Cancer kills over 9.5 million people each year, as per the World Health Organization (WHO), which makes it the second leading cause of human mortality. With the increasing prevalence of this disease in developed as well as developing countries, the pressure on the medical fraternity to find an effective treatment is increasing. Though there are numerous therapies available, such as surgery, radiation, chemotherapy, and targeted medication, cancer has a high chance of coming back. This is why extensive research is being put in by pharmaceutical and biotechnology companies.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/protein-a-resin-market/report-sample

Two of the novel and most promising answers to cancer that such activities have yielded thus far are monoclonal antibodies (mAb) and proteins. To produce both these biopharmaceuticals, laboratories require something known as protein A resin. Thus, with the increasing focus on protein-based research, the protein A resin market, which valued $486.4 million in 2019, seems set on the path to reaching $1,020.7 million by 2030, at a 7.0% CAGR during 2019-2030. Originally found in the Staphylococcus aureus (S. aureus) bacteria, the protein is used to purify mAbs and commercially produce proteins via the method of immunoprecipitation.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=protein-a-resin-market

On a geographical basis, the largest contribution to the protein A resin market has been made by North America till now, on account of the increasing requirement for therapeutics based on proteins, for the management of chronic diseases. In addition, the Food and Drug Administration (FDA) has approved numerous biopharmaceuticals, which is encouraging companies in the domain to use protein A resin for other similar products. In the coming years, Asia-Pacific (APAC) would witness the fastest rise in the consumption of this protein, as it is being increasingly used in medical research.

Hence, as the incidence of various chronic diseases surges, so will the demand for protein A resin, majorly to produce mAbs.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.